Last reviewed: June 12, 2026
Last updated: June 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Excess body weight and low testosterone frequently occur together, creating a metabolic cycle that makes weight loss harder. GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and improve insulin sensitivity, while testosterone supports muscle retention and metabolic rate during weight loss. Understanding how these therapies complement each other helps you achieve sustainable results.
How GLP-1 Therapy Supports Weight Loss During Hormonal Transitions
GLP-1 medications work by slowing gastric emptying, increasing satiety signals in the brain, and improving blood sugar control. When testosterone levels are suboptimal, the body often struggles to preserve lean muscle mass while losing fat, leading to metabolic slowdown. GLP-1 therapy addresses appetite regulation at the source, making it easier to maintain a calorie deficit without aggressive restriction. This mechanism is particularly valuable when hormonal changes have increased hunger or cravings.
Research shows that GLP-1 medications reduce food cravings by approximately 40-60% in clinical studies, independent of calorie counting. Patients report eating smaller portions naturally and feeling satisfied longer after meals. When combined with hormone optimization protocols, this appetite suppression becomes a foundation for sustainable weight loss rather than temporary restriction.
Understanding Testosterone's Role in Metabolic Health and Weight Management
Testosterone is essential for maintaining muscle mass, bone density, and metabolic rate. Low testosterone slows calorie burning by 5-10% and increases fat accumulation, especially around the abdomen. During weight loss, preserving muscle tissue is critical—muscle burns calories at rest, while fat loss without muscle retention leads to metabolic adaptation and weight regain. Testosterone therapy helps men and women retain lean body mass while losing fat, creating a more favorable body composition change.
Studies demonstrate that testosterone-deficient individuals lose more muscle per pound of weight lost compared to those with optimal levels. Optimizing testosterone before or during GLP-1 therapy ensures that fat loss isn't accompanied by muscle loss. This approach produces better long-term metabolic outcomes and reduces the likelihood of weight cycling.
GLP-Squared: Precision Dual-Compound Therapy for Metabolic Optimization
PlexusDx offers GLP-Squared Injection, a dual-compound medication combining semaglutide and tirzepatide in one formulation. This approach targets multiple metabolic pathways: semaglutide activates GLP-1 receptors for appetite suppression and glucose control, while tirzepatide adds GIP receptor activation for additional fat loss and insulin sensitivity. GLP-Squared starts at $249 per month for injection therapy, with pricing that remains flat regardless of dose escalation—meaning your dose may need to go up, but your price won't.
For patients optimizing testosterone alongside GLP-1 therapy, GLP-Squared provides streamlined metabolic support. The dual-compound approach reduces the number of injections while maximizing efficacy across complementary pathways. PlexusDx sources all compounds from licensed 503A compounding pharmacies and serves all 50 states without requiring insurance or membership fees. Treatment is HSA and FSA eligible, making precision therapy accessible.
Genetic Insights and Personalized Treatment Response
Individual responses to GLP-1 therapy vary significantly based on genetic factors. PlexusDx Precision Peptide Genetic Test identifies genetic variants in key metabolic pathways, including GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313. These variants influence how your body responds to GLP-1 medications, appetite regulation, and fat storage patterns. Understanding your genetic predispositions helps PlexusDx tailor treatment selection and dosing for optimal results.
The test analyzes 14 metabolic pathways, 49 peptide interactions, and 150+ genetic insights related to weight regulation and hormone sensitivity. For patients combining GLP-1 therapy with testosterone optimization, genetic testing reveals whether your metabolic pathways favor semaglutide, tirzepatide, or the dual GLP-Squared approach. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, providing personalized guidance that improves long-term treatment success.
Safety Considerations When Combining Therapies
Both GLP-1 medications and testosterone optimization require medical oversight and regular monitoring. GLP-1 side effects—primarily nausea, constipation, and appetite loss—typically diminish after 2-4 weeks as your body adjusts. Testosterone therapy requires baseline labs to ensure it's appropriate for your health profile and periodic monitoring to maintain optimal levels without exceeding safe ranges. PlexusDx providers coordinate with your healthcare team to ensure all therapies align with your complete health picture.
Contraindications exist: GLP-1 medications should not be used in individuals with personal or family history of thyroid cancer or multiple endocrine neoplasia. Testosterone therapy has specific considerations for prostate health and cardiovascular status. A comprehensive initial consultation with PlexusDx ensures that combining these therapies is safe and appropriate for your individual circumstances. Your medical team will establish baseline labs, determine appropriate starting doses, and schedule follow-up assessments.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Glp Squared starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I safely combine GLP-1 therapy with testosterone replacement?
Yes, when coordinated by healthcare providers. GLP-1 medications suppress appetite and improve metabolic health, while testosterone preserves muscle mass during weight loss. PlexusDx works with your medical team to ensure both therapies are appropriate for your health status and properly monitored throughout treatment.
How does GLP-Squared differ from using semaglutide or tirzepatide alone?
GLP-Squared combines semaglutide and tirzepatide in one injection, activating both GLP-1 and GIP receptors for enhanced appetite suppression and fat loss. Clinical data shows dual-receptor activation produces greater weight loss and metabolic improvements than single-agent therapy. GLP-Squared starts at $249 per month for injection, with flat pricing regardless of dose.
How does the Precision Peptide Genetic Test personalize my treatment?
The test identifies your genetic variants in GLP1R, GIPR, MC4R, and FTO genes, which influence your metabolic response to GLP-1 medications and appetite regulation patterns. PlexusDx uses these insights to recommend whether semaglutide, tirzepatide, or GLP-Squared best matches your genetic profile, plus appropriate dosing strategies. The test costs $99 as an add-on after your first treatment month.
What are the most common side effects when starting GLP-1 therapy?
Nausea, constipation, and reduced appetite are most common, typically resolving within 2-4 weeks as your body adjusts. Rare serious side effects include pancreatitis and severe dehydration, which is why PlexusDx requires medical supervision. Your provider will monitor your response and adjust your dose if needed to balance efficacy and tolerability.
Is PlexusDx medication covered by insurance?
PlexusDx does not require insurance and serves all 50 states. Treatment is HSA and FSA eligible. GLP-Squared Injection starts at $249 per month with flat pricing, making precision dual-compound therapy affordable without insurance coverage or membership fees.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Still Enjoy Food on Ozempic? Exploring the Relationship Between Weight Loss and Culinary Pleasure
Understanding When You Feel Side Effects of Semaglutide